news
Engineered T cell immunotherapy (such as chimeric antigen receptor T…
15 April 2019 | By Drug Target Review
Engineered T cell immunotherapy (such as chimeric antigen receptor T cell (CAR-T) and T cell receptor T cell (TCR-T) therapy), could potentially be used as a therapeutic strategy for tumour treatment.